National Health Investors, Inc. (NHI): Price and Financial Metrics
NHI Price/Volume Stats
Current price | $52.76 | 52-week high | $59.21 |
Prev. close | $51.62 | 52-week low | $47.54 |
Day low | $51.70 | Volume | 111,700 |
Day high | $52.81 | Avg. volume | 144,233 |
50-day MA | $55.00 | Dividend yield | 6.9% |
200-day MA | $52.68 | Market Cap | 2.29B |
NHI Stock Price Chart Interactive Chart >
NHI POWR Grades
- NHI scores best on the Quality dimension, with a Quality rank ahead of 85.76% of US stocks.
- NHI's strongest trending metric is Stability; it's been moving up over the last 26 weeks.
- NHI ranks lowest in Sentiment; there it ranks in the 25th percentile.
NHI Stock Summary
- Of note is the ratio of NATIONAL HEALTH INVESTORS INC's sales and general administrative expense to its total operating expenses; only 6.88% of US stocks have a lower such ratio.
- The ratio of debt to operating expenses for NATIONAL HEALTH INVESTORS INC is higher than it is for about 93.2% of US stocks.
- In terms of volatility of its share price, NHI is more volatile than merely 3.23% of stocks we're observing.
- Stocks with similar financial metrics, market capitalization, and price volatility to NATIONAL HEALTH INVESTORS INC are FRT, EPRT, NNN, AHH, and KIM.
- Visit NHI's SEC page to see the company's official filings. To visit the company's web site, go to www.nhireit.com.
NHI Valuation Summary
- NHI's EV/EBIT ratio is 22; this is 25.68% lower than that of the median Real Estate stock.
- Over the past 243 months, NHI's EV/EBIT ratio has gone up 4.1.
Below are key valuation metrics over time for NHI.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
NHI | 2023-12-29 | 7.8 | 1.9 | 23.0 | 22.0 |
NHI | 2023-12-28 | 7.9 | 2.0 | 23.3 | 22.3 |
NHI | 2023-12-27 | 8.0 | 2.0 | 23.6 | 22.5 |
NHI | 2023-12-26 | 7.9 | 2.0 | 23.4 | 22.3 |
NHI | 2023-12-22 | 7.9 | 2.0 | 23.4 | 22.3 |
NHI | 2023-12-21 | 7.9 | 2.0 | 23.4 | 22.3 |
NHI Growth Metrics
- Its 3 year revenue growth rate is now at -2.96%.
- The 3 year net cashflow from operations growth rate now stands at -17.4%.
- The 3 year cash and equivalents growth rate now stands at 597.72%.
The table below shows NHI's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-12-31 | 278.194 | 185.34 | 66.403 |
2022-09-30 | 277.191 | 192.341 | 71.017 |
2022-06-30 | 274.726 | 197.795 | 67.363 |
2022-03-31 | 289.157 | 192.627 | 84.873 |
2021-12-31 | 298.715 | 210.859 | 111.804 |
2021-09-30 | 310.287 | 213.122 | 142.469 |
NHI's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- NHI has a Quality Grade of B, ranking ahead of 75.92% of graded US stocks.
- NHI's asset turnover comes in at 0.102 -- ranking 203rd of 443 Trading stocks.
- HLNE, WRE, and PIPR are the stocks whose asset turnover ratios are most correlated with NHI.
The table below shows NHI's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-06-30 | 0.102 | 1 | 0.045 |
2021-03-31 | 0.105 | 1 | 0.046 |
2020-12-31 | 0.106 | 1 | 0.051 |
2020-09-30 | 0.107 | 1 | 0.053 |
2020-06-30 | 0.107 | 1 | 0.054 |
2020-03-31 | 0.106 | 1 | 0.054 |
NHI Price Target
For more insight on analysts targets of NHI, see our NHI price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $70.14 | Average Broker Recommendation | 2 (Hold) |
National Health Investors, Inc. (NHI) Company Bio
National Health Investors s a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The company was founded in 1991 and is based in Murfreesboro, Tennessee.
Latest NHI News From Around the Web
Below are the latest news stories about NATIONAL HEALTH INVESTORS INC that investors may wish to consider to help them evaluate NHI as an investment opportunity.
7 Elder Care Stocks to Take Advantage of Aging AmericaBuy these seven elder care stocks, as each one has ample exposure to the long-term "graying of America" trend. |
National Health Investors, Inc. (NYSE:NHI) Q3 2023 Earnings Call TranscriptNational Health Investors, Inc. (NYSE:NHI) Q3 2023 Earnings Call Transcript November 8, 2023 Operator: Greetings, and welcome to the National Health Investors Third Quarter 2023 Earnings Call. At the start of the presentation, all lines will be in a listen-only mode. Afterwards we will conduct a question-and-answer session. [Operator Instructions]. As a reminder, we are […] |
Q3 2023 National Health Investors Inc Earnings CallQ3 2023 National Health Investors Inc Earnings Call |
National Health Investors (NHI) Q3 Earnings: How Key Metrics Compare to Wall Street EstimatesThe headline numbers for National Health Investors (NHI) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. |
National Health Investors Inc (NHI) Reports Mixed Results in Q3 2023 EarningsNet Income Per Share Declines While FFO Shows Improvement |
NHI Price Returns
1-mo | -2.04% |
3-mo | 5.43% |
6-mo | 5.01% |
1-year | -1.29% |
3-year | -6.00% |
5-year | -13.12% |
YTD | -5.53% |
2023 | 14.57% |
2022 | -3.26% |
2021 | -11.74% |
2020 | -8.68% |
2019 | 13.67% |
NHI Dividends
Ex-Dividend Date | Type | Payout Amount | Change | ||||||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
Continue Researching NHI
Want to see what other sources are saying about National Health Investors Inc's financials and stock price? Try the links below:National Health Investors Inc (NHI) Stock Price | Nasdaq
National Health Investors Inc (NHI) Stock Quote, History and News - Yahoo Finance
National Health Investors Inc (NHI) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...